These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17457926)

  • 21. Characterization of a vaccinia virus strain used to produce smallpox vaccine in Argentina between 1937 and 1970.
    Lewis A; Bok K; Perez O; DeFillippo J; Paolazzi C; Gomez JA
    Arch Virol; 2005 Jul; 150(7):1485-91. PubMed ID: 15750861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses.
    Antoine G; Scheiflinger F; Dorner F; Falkner FG
    Virology; 1998 May; 244(2):365-96. PubMed ID: 9601507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use.
    Di Lullo G; Soprana E; Panigada M; Palini A; Agresti A; Comunian C; Milani A; Capua I; Erfle V; Siccardi AG
    J Virol Methods; 2010 Feb; 163(2):195-204. PubMed ID: 19778556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccinia virus strain LC16m8 defective in the B5R gene keeps strong protection comparable to its parental strain Lister in immunodeficient mice.
    Yokote H; Shinmura Y; Kanehara T; Maruno S; Kuranaga M; Matsui H; Hashizume S
    Vaccine; 2015 Nov; 33(45):6112-9. PubMed ID: 26241947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marker rescue of the host range restriction defects of modified vaccinia virus Ankara.
    Wyatt LS; Carroll MW; Czerny CP; Merchlinsky M; Sisler JR; Moss B
    Virology; 1998 Nov; 251(2):334-42. PubMed ID: 9837798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rapid, high-throughput vaccinia virus neutralization assay for testing smallpox vaccine efficacy based on detection of green fluorescent protein.
    Johnson MC; Damon IK; Karem KL
    J Virol Methods; 2008 Jun; 150(1-2):14-20. PubMed ID: 18387679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin.
    Jones-Trower A; Garcia A; Meseda CA; He Y; Weiss C; Kumar A; Weir JP; Merchlinsky M
    Virology; 2005 Dec; 343(1):128-40. PubMed ID: 16165184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Standardization of a neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation.
    Leparc-Goffart I; Poirier B; Garin D; Tissier MH; Fuchs F; Crance JM
    J Clin Virol; 2005 Jan; 32(1):47-52. PubMed ID: 15572006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya.
    Bejon P; Peshu N; Gilbert SC; Lowe BS; Molyneux CS; Forsdyke J; Lang T; Hill AV; Marsh K
    Clin Infect Dis; 2006 Apr; 42(8):1102-10. PubMed ID: 16575727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine.
    Vollmar J; Arndtz N; Eckl KM; Thomsen T; Petzold B; Mateo L; Schlereth B; Handley A; King L; Hülsemann V; Tzatzaris M; Merkl K; Wulff N; Chaplin P
    Vaccine; 2006 Mar; 24(12):2065-70. PubMed ID: 16337719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
    Fang M; Cheng H; Dai Z; Bu Z; Sigal LJ
    Virology; 2006 Feb; 345(1):231-43. PubMed ID: 16256161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.
    Carroll MW; Moss B
    Virology; 1997 Nov; 238(2):198-211. PubMed ID: 9400593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New generation smallpox vaccines: a review of preclinical and clinical data.
    Artenstein AW
    Rev Med Virol; 2008; 18(4):217-31. PubMed ID: 18283712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutting edge: mucosal application of a lyophilized viral vector vaccine confers systemic and protective immunity toward intracellular pathogens.
    Kastenmuller W; Gasteiger G; Stross L; Busch DH; Drexler I
    J Immunol; 2009 Mar; 182(5):2573-7. PubMed ID: 19234150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified vaccinia Ankara: potential as an alternative smallpox vaccine.
    McCurdy LH; Larkin BD; Martin JE; Graham BS
    Clin Infect Dis; 2004 Jun; 38(12):1749-53. PubMed ID: 15227622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice.
    Hanke T; McMichael AJ; Dennis MJ; Sharpe SA; Powell LA; McLoughlin L; Crome SJ
    Vaccine; 2005 Feb; 23(12):1507-14. PubMed ID: 15670887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
    Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
    J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.
    Meseda CA; Campbell J; Kumar A; Garcia AD; Merchlinsky M; Weir JP
    PLoS One; 2013; 8(6):e67984. PubMed ID: 23785523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuation of B5R mutants of rabbitpox virus in vivo is related to impaired growth and not an enhanced host inflammatory response.
    Stern RJ; Thompson JP; Moyer RW
    Virology; 1997 Jun; 233(1):118-29. PubMed ID: 9201221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain.
    Suter M; Meisinger-Henschel C; Tzatzaris M; Hülsemann V; Lukassen S; Wulff NH; Hausmann J; Howley P; Chaplin P
    Vaccine; 2009 Dec; 27(52):7442-50. PubMed ID: 19539582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.